Hyperglycemia in Acute Critically Ill COVID-19 PatientsCatia Cilloniz, Juan M. Pericàs, Anna Motos, Albert Gabarrús, Ricard Ferrer, Rosario Menéndez, Jordi Riera, Dario García-Gasulla, Oscar Peñuelas, Laia Fernández-Barat, José Ángel Lorente, David de Gonzalo-Calvo, Ferran Barbé, Antoni Torres
10.1016/j.arbres.2022.09.001
Arch Bronconeumol. 2023;59:51-6
Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired PneumoniaAne Uranga, Eloisa Urrechaga, Urko Aguirre, Maider Intxausti, Carlos Ruiz-Martinez, Maria Jose Lopez de Goicoechea, Cristina Ponga, Jose María Quintana, Cristina Sancho, Pilar Sanz, Pedro Pablo España
10.1016/j.arbres.2022.08.011
Arch Bronconeumol. 2022;58:802-8
Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS)Amos Lal, Juan Pablo Domecq Garces, Vikas Bansal, Aysun Tekin, Simon Zec, Ashish K. Khanna, Matthew A. Warner, Amy B. Christie, Rodrigo Cartin-Ceba, Valerie M. Banner-Goodspeed, Donna Lee Armaignac, Sreekanth R. Cheruku, Umamaheswara Raju, Yasir Tarabichi, Joshua L. Denson, Vishakha Kumar, Allan Walkey, Karen Boman, Neha Deo, Rahul Kashyap, Ognjen Gajic
10.1016/j.arbres.2022.07.017
Arch Bronconeumol. 2022;58:746-53